Krieg Arthur M
Coley Pharmaceutical Group, Wellesley, Massachusetts 02481, USA.
Nat Med. 2003 Jul;9(7):831-5. doi: 10.1038/nm0703-831.
The use of bacteria and bacterial extracts for immunotherapy has a checkered past. Recent developments in immunology reveal that these nonspecific immune activators actually work by triggering specific receptors that are expressed by subsets of immune cells. Identification of these receptors and the molecular signaling pathways that they activate has enabled a new era of specific targeted immunotherapy using chemically synthesized mimics of pathogen molecules.
将细菌及细菌提取物用于免疫疗法,其过往经历可谓波折。免疫学的最新进展表明,这些非特异性免疫激活剂实际上是通过触发免疫细胞亚群所表达的特定受体来发挥作用的。对这些受体及其激活的分子信号通路的识别,开启了一个使用病原体分子化学合成模拟物进行特异性靶向免疫疗法的新时代。